Post-COVID recovery is faster after an infection with the SARS-CoV-2 Omicron variant: a population-based cohort study
Open Access
- 18 November 2024
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 53 (2) , 657-665
Abstract
Purpose: Post-COVID-19 condition (PCC) poses a substantial burden to affected individuals, health care systems, and society as a whole. We examined factors associated with recovery from PCC, focusing on the vaccination status prior to infection and the virus variant. Methods: Our analyses are based on the population-based cohort study for digital health research in Germany (DigiHero). Respondents who reported a SARS-CoV-2 infection and COVID-related symptoms ≥ 12 weeks post-infection were classified as having PCC. Those with ongoing PCC were followed-up in six-month intervals based on their date of infection. We used a Cox model for interval-censored data to analyze PCC recovery. Results: Among the 4,529 respondents with PCC included in our analyses, about 26%, 19%, 36%, and 44% of those infected during dominance of the SARS-CoV-2 wildtype, Alpha, Delta, and Omicron variant had recovered one year after infection, respectively. When stratifying by virus variant, vaccination was not associated with a faster recovery. Conversely, those infected with Omicron (HR = 2.20; 95%CI: 1.96–2.48) or Delta (HR = 1.69; 95%CI: 1.43–2.01) recovered faster than those infected with the SARS-CoV-2 wildtype or Alpha strain. Conclusion: Although the recovery from PCC is faster for the newer virus variants, still a substantial fraction of those who developed PCC after an infection with the Omicron variant report prolonged persistence of symptoms.Keywords
Funding Information
- Martin-Luther-Universität Halle-Wittenberg
This publication has 26 references indexed in Scilit:
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onsetInternational Journal of Infectious Diseases, 2023
- Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort studyeClinicalMedicine, 2023
- COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysisBrain, Behavior, and Immunity, 2023
- COVID-19 long-term sequelae: Omicron versus Alpha and Delta variantsInfectious Diseases Now, 2023
- Factors Associated With Long COVID Symptoms in an Online Cohort StudyOpen Forum Infectious Diseases, 2023
- A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participantsInternational Journal of Infectious Diseases, 2022
- Symptoms and risk factors for long COVID in non-hospitalized adultsNature Medicine, 2022
- SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysisBMC Infectious Diseases, 2022
- Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysisJournal of Medical Virology, 2021